Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
W
Wardwizard Healthcare Ltd
Score 48/100• Risky
Wardwizard Healthcare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health75/100
Valuation 100/100 · PB -0.3402
Technical Momentum
1M — 6M 88.11% 1Y 117.692%
Confidence100%
No promoter pledgeDecent revenue growth
Thin margins
#181
View details ➜
W
Wanbury Ltd
Score 48/100• Risky
Wanbury Ltd presents several risks with limited growth prospects and high valuation metrics, making it a risky investment at this time.
Company’s Health41/100
Valuation 20/100 · PB 13.9637
Technical Avoid
1M -4.792% 6M -21.058% 1Y -22.388%
Confidence100%
High debt/equityPromoter pledge present
#182
View details ➜
S
Saakshi Medtech and Panels Ltd
Score 48/100• Risky
The stock presents several risks with limited growth prospects and weak financial metrics, making it a risky investment.
Company’s Health72/100
Valuation 40/100 · PB 3.3376
Technical Avoid
1M 8.93% 6M 6.615% 1Y -23.425%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#183
View details ➜
U
Unjha Formulations Ltd
Score 48/100• Decent
Unjha Formulations Ltd shows potential but faces challenges in execution and market sentiment.
Company’s Health61/100
Valuation 40/100 · PB 3.5687
Technical Avoid
1M -6.185% 6M 7.309% 1Y -22.674%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#184
View details ➜
S
Sunil Healthcare Ltd
Score 48/100• Risky
Sunil Healthcare Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
Company’s Health45/100
Valuation 80/100 · PB 1.0464
Technical Avoid
1M -6.254% 6M -12.5% 1Y -21.153%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#185
View details ➜
S
Soni Medicare Ltd
Score 48/100• Risky
Soni Medicare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health51/100
Valuation 20/100 · PB 36.0368
Technical Avoid
1M 1.596% 6M 40.627% 1Y 177.283%
Confidence100%
No promoter pledge
Weak ROEHigh debt/equity
#186
View details ➜
K
Kwality Pharmaceuticals Ltd
Score 48/100• Risky
Kwality Pharmaceuticals Ltd presents a mixed outlook with significant risks, particularly in execution and market sentiment.
Company’s Health90/100
Valuation 40/100 · PB 3.8173
Technical Avoid
1M 14.132% 6M -3.871% 1Y 11.514%
Confidence100%
Low leverage (D/E)No promoter pledge
#187
View details ➜
Z
Zota Health Care Ltd
Score 48/100• Risky
Zota Health Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health63/100
Valuation 20/100 · PB 22.7129
Technical Momentum
1M 7.96% 6M 68.341% 1Y 151.992%
Confidence100%
Decent revenue growth
Weak ROEPromoter pledge present
#188
View details ➜
W
Wockhardt Ltd
Score 48/100• Risky
Wockhardt Ltd presents several risks, particularly in growth consistency and balance sheet strength, making it a risky investment at this time.
Company’s Health30/100
Valuation 40/100 · PB 4.6797
Technical Avoid
1M 0.323% 6M -24.842% 1Y -3.386%
Confidence100%
Low leverage (D/E)
Weak ROEPromoter pledge present
#189
View details ➜
V
Vivo Bio Tech Ltd
Score 48/100• Risky
Vivo Bio Tech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health57/100
Valuation 100/100 · PB 0.8284
Technical Avoid
1M -9.099% 6M -23.016% 1Y -21.804%
Confidence100%
No promoter pledgeHealthy profit margins
Weak ROE
#190
View details ➜
V
Vivanza Biosciences Ltd
Score 48/100• Risky
Vivanza Biosciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health26/100
Valuation 60/100 · PB 2.0606
Technical Avoid
1M -5.53% 6M -15.353% 1Y -45.6%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEHigh debt/equity
#191
View details ➜
V
Vaidya Sane Ayurved Laboratories Ltd
Score 48/100• Risky
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health79/100
Valuation 20/100 · PB 5.2034
Technical Avoid
1M 1.292% 6M 70.543% 1Y 89.59%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#192
View details ➜
U
Unichem Laboratories Ltd
Score 48/100• Decent
Unichem Laboratories has a decent score, indicating potential but with notable risks and inconsistencies in growth and profitability.
Company’s Health68/100
Valuation 80/100 · PB 1.3095
Technical Avoid
1M -3.436% 6M -27.708% 1Y -40.278%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#193
View details ➜
S
Sharma East India Hospitals and Medical Research Ltd
Score 48/100• Risky
The company faces significant challenges in terms of growth, profitability, and valuation, making it a risky investment.
Company’s Health74/100
Valuation 40/100 · PB 3.6022
Technical Watch
1M 8.519% 6M 80.066% 1Y 91.909%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#194
View details ➜
S
Sangani Hospitals Ltd
Score 48/100• Decent
Sangani Hospitals Ltd shows potential with consistent growth, but faces challenges in profitability and valuation metrics.
Company’s Health84/100
Valuation 60/100 · PB 2.2275
Technical Avoid
1M -12.651% 6M -19.67% 1Y -16.452%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#195
View details ➜
Showing 181 to 195 of 301 (21 Pages)